Blood glucose outcomes of anti-retroviral therapy naïve Ugandan people with HIV with pre-diabetes mellitus initiated on dolutegravir for 48 weeks.
Res Sq
; 2023 Aug 03.
Article
in En
| MEDLINE
| ID: mdl-37577475
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Observational_studies
Language:
En
Journal:
Res Sq
Year:
2023
Document type:
Article